Pharmacology and gastrointestinal safety of lumiracoxib, a novel cyclooxygenase-2 selective inhibitor: An integrated study.
Atherton C, Jones J, McKaig B, Bebb J, Cunliffe R, Burdsall J, Brough J, Stevenson D, Bonner J, Rordorf C, Scott G, Branson J, Hawkey CJ.
Atherton C, et al. Among authors: cunliffe r.
Clin Gastroenterol Hepatol. 2004 Feb;2(2):113-20. doi: 10.1016/s1542-3565(03)00318-5.
Clin Gastroenterol Hepatol. 2004.
PMID: 15017615
Clinical Trial.